Home > Browse Research > Life Sciences > Pharmaceuticals > Biopharmacology

Biopharmacology: market research reports

Biopharmacology is the branch of pharmacology that studies the use of biotechnologic originated drugs, or biopharmaceuticals. Biopharmacology research in biopharmaceuticals concerns medical drugs produced using biotechnology that can include proteins, antibodies, nucleic acids, DNA, RNA or antisense technologies. Find the information you need on the biopharmacology industry in our collection of market research reports that provide insights into product and market trends, analyses, opportunities, projections, sales, and marketing strategies.

Specifics on market share, segmentation, size, and growth in the US and global markets are also featured.

Biopharmacology market research reports and industry analysis

Biotechnology in the US - Industry Risk Rating Report 4/24/2013 \| published by: IBISWorld ... the business operating environment'. The report looks at the operational risk associated with this industry. Three types of risk are recognized in our analysis. These are: risk arising from within the industry itself (structural risk), ... \| read more...	$1,020.00
Biotechnology Product Manufacturing 3/25/2013 \| published by: First Research, Inc. ... US-based Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), and Monsanto; Cangene (Canada) and ADIMMUNE (Taiwan); and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). The global biotechnology industry includes ... \| read more...	$129.00
Biotechnology Products Markets in China 3/15/2013 \| published by: Asia Market Information & Development Company ... investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in ... \| read more...	$2,000.00
Biotechnology in the US - Industry Market Research Report 3/7/2013 \| published by: IBISWorld ... increasingly aging population will drive solid revenue growth in the next five years. Furthermore, federal mandates will likely benefit the industry, causing research and development to increase over the period. Firms in this industry primarily ... \| read more...	$910.00
The Laclede Group, Inc. - SWOT, Strategy and Corporate Finance Report 1/1/2013 \| published by: MarketLine ... and corporate actions, providing a 360° view of the company. Features: Detailed information on The Laclede Group, Inc. required for business and competitor intelligence needs A study of the major internal and external factors affecting ... \| read more...	$175.00
Single-Use Technologies for Biopharmaceuticals: Global Markets 1/1/2013 \| published by: BCC Research ... for 2012, and projections of compound annual growth rates (CAGRs) through 2017 In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, ... \| read more...	$5,450.00
541711 Research and Development In Biotechnology: State Industry Market Evaluator 12/31/2012 \| published by: BizMiner ... volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include failure rates (firms, establishments, small business, startups). startup activity rates ... \| read more...	$699.00
2012 Biotechnology Research Review 12/1/2012 \| published by: BCC Research ... that have entered the market worldwide and forecasts the growth prospects for these products. A detailed analysis of the kinase inhibitors industry structure has been conducted. Revenues are broken down by region. Sales figures are ... \| read more...	$950.00
Downstream Processing in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness 11/1/2012 \| published by: GBI Research ... in Biopharmaceuticals - Adoption of Disposable Technology at Improved Economies of Scale to Optimize Production Efficiency and Cost-effectiveness”, which provides key data, information and analysis of the Contract Manufacturing Organization (CMO) industry, and the downstream ... \| read more...	$3,500.00
Chinese Markets for Biotechnology 10/1/2012 \| published by: Asia Market Information & Development Company ... environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China ... \| read more...	$2,000.00
Biotechnology And Pharmaceuticals Report 9/17/2012 \| published by: Wall Street Transcript ... current regulatory environment for biotech companies and the potential impact that federal health care reform may have on the sector. He talks about some of the headwinds affecting biotech and pharma, such as competition risk ... \| read more...	$175.00
Global Active Pharmaceutical Ingredients (API) and High Potency API (HPAPI) Industry Outlook to 2016 - Shifting Focus Towards Biotechnology 9/1/2012 \| published by: Ken Research ... global API industry based on the regions such as North America, Asia-Pacific and Western Europe, market segmentation by generic and innovator API and on the basis of revenue earned from pharmaceutical raw materials for own ... \| read more...	$1,200.00
Pharmaceutical Launch Sequencing: Mapping Commercialization Opportunities to Maximize Global Value and Expand Market Access 9/1/2012 \| published by: Cutting Edge Information ... lower revenue potential worldwide. To maximize product revenue, especially for innovative drugs, companies must carefully prioritize the order in which different markets receive their products. Global launch sequencing is a complex task requiring input from ... \| read more...	$7,695.00
e-Clinical Trials Solutions/Suite/Technologies Market – (CTMS, CDMS, EDC, IVRS, ePRO & IRB Systems) Global Trends, Opportunities & Forecasts (2012 – 2017) 8/24/2012 \| published by: MarketsandMarkets ... planning, preparation, performance, and reporting of clinical trials, including participant information, trial and filing deadlines and other important milestones. The global eClinical solutions market is estimated to grow at a CAGR of 13.4% during the ... \| read more...	$4,650.00
Biotechnology in Australia - Industry Market Research Report 8/15/2012 \| published by: IBISWorld ... biotechnology products and services. Within the Australian context, this industry covers biotechnology research and development, biotechnology licensing, biotechnology product manufacture, and biotechnology product wholesale. This report covers the scope, size, disposition and growth of the ... \| read more...	$930.00
Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings 7/10/2012 \| published by: GBI Research ... Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings”, which provides insights into the impact of biobetter therapies on the top selling biologic therapeutics, the regulatory procedure ... \| read more...	$3,500.00
China Pharmaceutical & Biotechnology Monthly 7/1/2012 \| published by: GBI ... opportunities and challenges China presents. Its contents include top stories, key facts and figures, news in general, policy and regulations, investments and finance, company, trade, research & development and IP & legal. It also has ... \| read more...	$59.00
United States Market for Psoriatic Arthritis Pharmacotherapy 6/29/2012 \| published by: Frost & Sullivan ... the background standard of care. Included in the study are products on the market and products in development as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The ... \| read more...	$6,000.00
2012 Outsourcing Guide for the Drugs & Biotechnology Industry 6/15/2012 \| published by: Information Services Group (ISG) ... within the Drugs & Biotechnology vertical and subvertical levels, including 'Biotechs' and 'Pharmaceuticals'. This report from the ISG Momentum Market Trends & Insights series can help service providers develop an effective go-to-market strategy characterized by ... \| read more...	$1,500.00
Global Markets for Membrane Technology for Pharmaceuticals 6/1/2012 \| published by: BCC Research ... pharmaceutical market was $2.3 billion in 2010 and $2.7 billion in 2011. It is expected to grow to $4.4 billion in 2016, a CAGR of 9.9% between 2011 and 2016. The life science laboratory market ... \| read more...	$5,450.00
Interferon Market Forecast to 2015 6/1/2012 \| published by: RNCOS ... interferons (IFN), a family of glycoprotein cytokines which have antiviral, anti-proliferative, and immuno-modulatory properties, is expected to cross the US$ 10 Billion-mark by 2015. Increasing number of Hepatitis B and Hepatitis C cases across the ... \| read more...	$400.00
Biotechnology in India 5/1/2012 \| published by: Global Industry Analysts ... Also, a six-year historic analysis is provided for this market. The report profiles 102 companies including many key and niche players such as Advanced Enzymes Technologies Ltd., Ajeet Seeds Ltd., Anthem BioSciences Pvt. Ltd., Bharat ... \| read more...	$3,950.00
Research Report on Chinese Bio-pharmaceutical Industry, 2012 3/21/2012 \| published by: China Research and Intelligence Co., Ltd. ... bio-pharmaceutical industry. "Bio-pharmaceutical" in the report only refers to human biological products. Chinese biological product industry is an emerging industry which has only over 20 years of history. In 2011, the sales revenue of Chinese ... \| read more...	$3,000.00
United States Biotechnology Industry - Porter’s Five Forces Strategy Analysis 3/1/2012 \| published by: Aruvian's R'search ... quality of life for the world’s citizens. The majority of U.S. biotechnology firms are pursuing markets in human health care. Aruvian's R'search analyzes the US Biotechnology industry in the Michael Porter’s Five Forces Analysis. It ... \| read more...	$175.00
World Biological Drugs Market 2012-2022 2/14/2012 \| published by: Visiongain ... you assess potential sales trends at world market, submarket, product and regional level to 2022. How will 20 leading biologics - including Avastin, Enbrel, Humira and Herceptin - perform from 2012? Our investigation gives you ... \| read more...	$2,739.00

< prev 1 2 next >